Published On: Wed, Nov 2nd, 2016

Valeant, in Push for Cash, Looks to Sell Stomach-Drug Business – Wall Street Journal


Wall Street Journal

Valeant, in Push for Cash, Looks to Sell Stomach-Drug Business
Wall Street Journal
Valeant Pharmaceuticals International Inc. is in advanced talks to sell a big stomach-drug business to Japan’s Takeda Pharmaceutical Co. for about $10 billion, a move seen easing pressure on Valeant over its hefty debt load. The companies could reach a …
Valeant says in talks to sell Salix stomach-drug businessReuters
Valeant may sell a family jewel to survive, and stock is soaringBusiness Insider

all 149 news articles »

Powered by WPeMatico

Comments are closed.

Videos

Most Popular Posts